Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AP Antivirals for treatment of HCV infections
J05AP03 Boceprevir
D08876 Boceprevir (INN/USAN)
Drug groups [BR:br08330]
Antiviral
DG03198 Anti-HCV agent
DG02001 HCV NS3/4A protease inhibitor
D08876 Boceprevir
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
D08876 Boceprevir
Antimicrobials [BR:br08307]
Antivirals
Polyprotein cleavage inhibitor
HCV NS3/4A inhibitor
D08876 Boceprevir (INN/USAN)
Antimicrobials abbreviations [BR:br08327]
Antivirals
Polyprotein cleavage inhibitor
HCV NS3/4A inhibitor
D08876 Boceprevir (INN/USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08876
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D08876
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08876
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08876